Antimicrobial Resistance: A Growing Global Health Challenge and What Can Be Done
Antimicrobial resistance (AMR) is one of the most important challenges for global health, undermining our ability to treat common infections, complicating medical procedures, and increasing costs across health systems.
Driven by misuse of antibiotics, limited access to rapid diagnostics, and interconnected human-animal-environment pathways, AMR demands coordinated action across sectors and countries.
Why AMR matters
– Longer, more severe infections: When bacteria, viruses, fungi, or parasites no longer respond to standard treatments, illnesses last longer and complications increase.
– Threats to routine care: Surgeries, chemotherapy, and care for premature infants rely on effective antimicrobials; resistance raises risks for these procedures.
– Economic burden: Resistant infections lead to longer hospital stays, more intensive care, and higher treatment costs that strain both households and health systems.
– One Health interplay: Antibiotic use in human medicine, animal agriculture, and environmental contamination are interconnected, so isolated actions are less effective.
Key drivers
– Overuse and misuse of antibiotics in humans and animals, including unnecessary prescriptions and inappropriate dosing.
– Limited access to affordable, high-quality diagnostics that would guide targeted therapy rather than broad-spectrum use.
– Poor infection prevention and control in healthcare settings and inadequate water, sanitation, and hygiene (WASH) infrastructure that facilitate spread.
– Gaps in surveillance and data sharing, which hinder timely responses and the tracking of resistance patterns.
– Insufficient investment in new antimicrobials, alternative therapies, and rapid diagnostic tools.
Effective strategies to curb AMR
– Strengthen antibiotic stewardship: Clinicians and health systems should adopt stewardship protocols that prioritize appropriate prescribing, de-escalation when possible, and shorter, evidence-based treatment durations.
– Expand rapid diagnostics: Point-of-care tests and faster laboratory methods allow targeted therapy, reducing unnecessary broad-spectrum antibiotic use.
– Improve surveillance: Robust, standardized surveillance systems across human, animal, and environmental sectors enable early detection and coordinated responses.
– Invest in vaccines and prevention: Vaccination reduces the incidence of infections that would otherwise require antibiotic treatment. Strong infection prevention measures in hospitals and community WASH improvements lower transmission.
– Regulate agricultural use: Phasing out routine use of medically important antibiotics for growth promotion and disease prevention in healthy animals reduces selection pressure for resistance.
– Foster innovation and market incentives: Public–private partnerships, novel reimbursement models, and pull incentives can stimulate development of new antimicrobials and alternative approaches such as phage therapies or immune-based treatments.
– Promote global cooperation: AMR crosses borders; international coordination on surveillance, research, and stewardship alignment amplifies impact.
What individuals can do
– Use antibiotics only when prescribed by a qualified health professional and complete the full course as directed.
– Never share or use leftover antibiotics; return unused medications through appropriate disposal programs when available.
– Prioritize vaccination and routine WASH practices—hand hygiene and safe food handling— to reduce infection risk.
– Support responsible farming and consumer choices when possible, such as products from systems that avoid routine antibiotic use.
Moving forward requires sustained political will, cross-sector collaboration, and investment in systems that prevent infections, preserve effective treatments, and accelerate novel solutions. With coordinated action—spanning clinicians, researchers, policymakers, industry, farmers, and the public—progress against antimicrobial resistance is achievable and essential for protecting global health.